BMAL1 and cancer: The circadian clock, governed by core-clock genes such as BMAL1 and PER2, orchestrates various physiological processes, including metabolism,79 cell proliferation,19 and responses to medications,80 making them a crucial target for improving cancer therapy outcomes.